Please assess the completion status of the following clinical trial:

Trial Title: Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participated in the 'GH-dose catch-up study' 98- 0198-003.~* Midparental height reached (difference less than 0.6 SDS)~* Prepubertal at start of the study (girls =B 1, boys: testes :\<; 3ml).~* Signed written informed consent from the patient's parents (and the child if old enough)~Exclusion Criteria:~* Disease affecting growth other than correctly treated hypothyroidism.~* Incapable of following the study protocol (i.e. bad compliance in the previous study).~* Puberty (\> breast stage 2, or testes \> 4ml).~* Poor compliance.

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Interventional (Type: ACTIVE_COMPARATOR): Unchanged dose Genotropin
- Interventional 2 (Type: ACTIVE_COMPARATOR): reduced dose 50% Genotropin

Based on this trial design, predict the completion outcome and termination type (if applicable).